A carregar...

Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.

The deprenyl and tocopherol antioxidative treatment (DATATOP) study has shown that selegiline (deprenyl), with or without tocopherol, reduces physical and psychological deficits in patients with Parkinson's disease within one month of treatment and reduces the probability of reaching a primary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Ward, C D
Formato: Artigo
Idioma:Inglês
Publicado em: 1994
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1072455/
https://ncbi.nlm.nih.gov/pubmed/8126510
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!